Assura Plc (LON:AGR – Get Free Report) insider Jayne Cottam bought 663 shares of the company’s stock in a transaction that occurred on Tuesday, August 5th. The shares were bought at an average price of GBX 49 ($0.65) per share, with a total value of £324.87 ($433.97).
Jayne Cottam also recently made the following trade(s):
- On Tuesday, July 22nd, Jayne Cottam sold 94,230 shares of Assura stock. The shares were sold at an average price of GBX 50 ($0.67), for a total transaction of £47,115 ($62,937.48).
- On Wednesday, July 9th, Jayne Cottam acquired 607 shares of Assura stock. The shares were bought at an average cost of GBX 50 ($0.67) per share, with a total value of £303.50 ($405.42).
Assura Trading Down 0.2%
Shares of AGR stock opened at GBX 49.10 ($0.66) on Thursday. Assura Plc has a 12-month low of GBX 35.24 ($0.47) and a 12-month high of GBX 50.95 ($0.68). The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. The stock’s 50-day moving average price is GBX 49.88 and its 200-day moving average price is GBX 46.45. The stock has a market capitalization of £1.60 billion, a price-to-earnings ratio of -46.93, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37.
Assura Company Profile
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
See Also
- Five stocks we like better than Assura
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- RSI Stock Soars 22% On Q2 Blowout—Will PENN Match the Momentum?
- Canadian Penny Stocks: Can They Make You Rich?
- How DigitalOcean’s Focus Is Fueling Explosive Growth
- What Investors Need to Know to Beat the Market
- Can Celsius Stock Keep Its Momentum Going Any Longer?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.